Abstract:This report describes the use of alteplase in a dog for thrombolysis of intravesicular thrombi. In patients that develop intravesicular thrombi, intravesical instillation of alteplase can be considered as a method for dissolution of these thrombi.
“…For one of them [ 23 ], only the abstract was available and the recoverable data were considered. Among the non-pediatric papers, we also included three case reports about animals: two concerning two dogs [ 24 , 25 ] and one about a cat [ 26 ].…”
Section: Resultsmentioning
confidence: 99%
“…In the veterinary setting, the overall attention has focused only on alteplase application [ 24 , 25 , 26 ]. Similarly to Olarte et al [ 2 ], Pineda’s group diluted 1 mg of alteplase in 10 mL of saline solution and administered 5 mL of the solution into a dog bladder, for 1 h. The procedure was repeated 8 h later and then six times at one-month intervals, due to frequent hematuria episodes and new clot development.…”
Bladder blood clots represent an infrequent urinary condition in children. They usually result from hematuria with many underlying causes, such as urinary tract infections and urethral/bladder traumas. Treatment options for clot removal include trans-urethral or suprapubic bladder irrigation and, if unsuccessful, endoscopic management under general anesthesia with a resectoscope. In younger male children, however, the repeated passage of a trans-urethral resectoscope may be challenging and traumatic, due to the small lumen diameter. Eventually, an open surgical approach can be required in many patients. Few anecdotal non-surgical approaches have been proposed for the management of bladder blood clots in children. This review aims to summarize the conservative techniques described in the literature with the instillation of intravesical agents, analyzing the different strategies and their advantages.
“…For one of them [ 23 ], only the abstract was available and the recoverable data were considered. Among the non-pediatric papers, we also included three case reports about animals: two concerning two dogs [ 24 , 25 ] and one about a cat [ 26 ].…”
Section: Resultsmentioning
confidence: 99%
“…In the veterinary setting, the overall attention has focused only on alteplase application [ 24 , 25 , 26 ]. Similarly to Olarte et al [ 2 ], Pineda’s group diluted 1 mg of alteplase in 10 mL of saline solution and administered 5 mL of the solution into a dog bladder, for 1 h. The procedure was repeated 8 h later and then six times at one-month intervals, due to frequent hematuria episodes and new clot development.…”
Bladder blood clots represent an infrequent urinary condition in children. They usually result from hematuria with many underlying causes, such as urinary tract infections and urethral/bladder traumas. Treatment options for clot removal include trans-urethral or suprapubic bladder irrigation and, if unsuccessful, endoscopic management under general anesthesia with a resectoscope. In younger male children, however, the repeated passage of a trans-urethral resectoscope may be challenging and traumatic, due to the small lumen diameter. Eventually, an open surgical approach can be required in many patients. Few anecdotal non-surgical approaches have been proposed for the management of bladder blood clots in children. This review aims to summarize the conservative techniques described in the literature with the instillation of intravesical agents, analyzing the different strategies and their advantages.
“…12 There are also reports, in both the human and veterinary literature, of intravesicular administration of alteplase to successfully and safely dissolve urinary bladder blood clots. 14–16 Given this background, investigation of the intra-device use of alteplase to dissolve SUB blood clot occlusions in cats seems warranted. However, only anecdotal mention of it has been reported.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, the intravesicular doses used (especially in case 2) were much larger than the typical range of 0.5–1 mg reported in both the both the human pediatric and veterinary literature. 14–16 Finally, in this series, cats with large intravesicular blood clots received intravesicular infusion of alteplase via a transurethral urinary catheter alone or in addition to infusion through the SUB port. Thus, the importance of the intravesicular route of infusion in this subset of cats also needs to be determined.…”
Case series summary Seven cats were found to have postoperative subcutaneous ureteral bypass (SUB) occlusion secondary to blood clot formation. An increase in serum creatinine led to imaging and clot detection in all but one case. Alteplase, a tissue plasminogen activator, was infused into the SUB via the port in four cats, intravesicularly via a transurethral urinary catheter in one cat, and by both routes in two cats. Patency of the SUB was re-established in all cats within 2 days. No short- or long-term complications directly attributed to alteplase administration were observed. Relevance and novel information The results of this case series suggest that alteplase infusion via either the SUB port and/or a transurethral catheter should be considered prior to surgical intervention for the treatment of postoperative SUB occlusion secondary to a blood clot.
“…The use of Alteplase for the urinary tract has yet to be approved by the Food and Drug Administration. Alteplase studies have been conducted on animals 4 and in vitro 5 for thrombolytic therapy urinary tract but yet not utilized in humans. The present case report demonstrates the first case of an alteplase installation clot dissolution in the ureter using the nephrostomy tube for an outpatient.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.